Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia

PURPOSE: The decision to re-induce patients with acute myeloid leukemia (AML) based on results of the day 14 bone marrow (BM) biopsy is variable and lacks evidence based data. The aim of our review was to evaluate the accuracy of a day 14 BM biopsy in determining the need for re-induction chemothera...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Morris, Tod A., DeCastro, Carlos M., Diehl, Louis F., Gockerman, Jon P., Lagoo, Anand S., Li, Zhiguo, Moore, Joseph O., Rizzieri, David A., Rao, Arati V.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3753071/
https://ncbi.nlm.nih.gov/pubmed/23046833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.09.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars